No.of studies LogRR 95%CI P value
Complications
Deaths 5 -1.08 -2.59-0.43 0.16
Myocardial infarctions
5
0.28
-1.37-1.92
0.74
Recurrent strokes
5
0.26
-1.39-1.91
0.75
Hernia
5
-0.97
-2.02-0.07
0.07
Hemorrhage of the digestive tract
5
-0.72
-2.00-0.56
0.27
Hemorrhagic transformation at 24 hours
2
0.94
-0.20-2.08
0.11
Fever (>38 °C) 4 -0.09 -0.89-0.71 0.82
Event
All events
At least 1 adverse event 3 -0.12 -0.85-0.61 0.75
Any serious adverse event 4 -0.06 -1.99-1.87 0.95
Frequent or special interest adverse events
Lung infection 5 0.06 -0.58-0.69 0.86
Urinary tract infection 5 0.02 -0.95-0.99 0.97
Abnormal laboratory liver-function test 3 -0.04 -2.26-2.18 0.97
Gastrointestinal disorders 3 -0.04 -2.26-2.18 0.97
Herpes virus infection 4 -0.03 -1.96-1.90 0.98
Arrhythmia 3 0.67 -1.33-2.66 0.51
Macular edema 3 -0.04 -2.26-2.18 0.97